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Cytogenetic Classification of Renal Cell Cancer
Eva van den Berg, Trijnie Dijkhuizen, J. Wolter Oosterhuis, 
Ad Geurts van Kessel, Bauke de Jong, and Stephan Störkel
ABSTRACT: Cytogenetic and molecular genetic investigations in cancer are important tools to address 
problems of oncogenesis and tumor progression, o f classification, and of diagnosis of tumors. A  combi­
nation of advanced molecular genetic, cytogenetic, and (immuno) histopathologic analysis will contrib­
ute significantly to the elucidation of the oncogenic steps that lead to immortalization and subsequent 
malignant behavior„ In this review written on the occasion of Dr. Avery Sandberg's 75th anniversary, we 
will present a model for the pathogenesis o f renal cell tumors based on a new cytomorphologic classifi­
cation and our (cyto)genetic analysis of about 175 renal cell tumors, together with the accumulated data 
in the literature. © Elsevier Science Inc., 1997
INTRODUCTION 
Renal Cell Cancer
Renal cell adenomas (RCA) and carcinomas (RCC) consti­
tute a heterogeneous group of tumors and this heterogene­
ity is a well-known complicating factor in the diagnosis. 
The histogenesis of renal cell cancer has been controver­
sial for a long time, especially in terms of the thesis origi­
nally expressed by Virchow and advocated by Grawitz [1] 
that certain clear cell epithelial renal tumors are derived 
from ectopic adrenocortical elements. This has led to the 
term “hyp er nephroma” or Grawitz tumor and finally also 
to the term “hypernephroid renal carcinoma.” Although 
true hyperaephrogenic tumors do rarely occur in the kid­
ney, the hypernephrogenic theory of the clear cell epithe­
lial renal tumors has been questioned for a long time and 
preference is given instead to the renal tubular histogene­
sis. The evidence that the usual (nonembryonic) renal ade­
nomas and carcinomas in all their variants derive, in 
principle, from the mature uriniferous tubule has been 
promoted and consolidated by animal experiments with 
carcinogens and observation of prestages and early stages 
of epithelial renal tumors in hum an kidneys [2-4],
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CLASSIFICATION OF RENAL CELL CANCER
The aim of a histopathologic classification is to use morpho­
logic criteria to identify biologically distinct disease states, 
the recognition of which are of clinical value [5], Therefore, 
modern tumor classifications generally are cyto logic ally ori­
entated, i.e., emphasizing histogenesis and differentiation. 
The formation of such a classification for epithelial renal 
tumors has proved difficult. Previous attempts have been 
"closed” systems using histology as the basis both for 'the 
classification and for the recognition of the distinct spe­
cies [5].
Currently two morphologic classifications are used: 
one according to the WHO/AFIP [6] and one according to 
Thoenes et al. [7] and Störkel [8], As stated in the latter, 
eight different subtypes of RCA/RCC can be distinguished, 
related to the basic cell types of the nephron from which 
they are derived: (1) RCCs of the clear cell type, (2) RCAs/ 
RCCs of the chromophilic cell type, (3) RCAs/RCCs of the 
chromophobic cell type, (4) RCCs of the duct Bellini cell 
type, (5) RCCs of the transitional cell type, (6) RCCs of the 
neuroendocrine type, (7) RCAs of the oncocytic type, and 
(8) RCAs of the metanephroid type, These types show pheno- 
typical/histogenetical relations to different parts or cell types, 
respectively, of the nephron collecting duct system [8],
Basically three growth patterns, which can be deduced 
from the tubule, are distinguished: (1) compact (subtype: aci­
nar); (2) tubulopapillary, and (3) cystic. Principally, in a 
given tumor, all growth patterns can occur simultaneously, 
but generally one of them predominates. There are relation­
ships to the cell types, although not exclusive: clear cell and 
chromophobe type are predominantly related to compact 
growth, chromophilic to tubulopapillary growth, oncocytic 
(true ‘renal oncocytoma’) is related to acinar, and Bellini 
duct to both compact and tubulopapillary growth.
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The renal cell carcinomas are graded with respect to nu­
clear atypia, including the size of nucleoli, supplemented by 
cytoplasmic features, e.g. diminution of basic features, aug­
mentation of eos i no ph ilia/granularity (mitochondria), and 
spindle/pleomorphic cell form. Presently, according to these 
parameters three grades (Gl, G2, G3/4) are distinguished [7],
CYTOGENETIC AND MORPHOLOGIC CORRELATIONS
Cytogenetics allows the classification of tumors with 
respect to their genotypic differences. Figure 1 summarizes 
and correlates both morphology and cytogenetic data with 
respect to histogenetic aspects of most of the basic tumor 
subtypes mentioned above. RCCs of the transitional cell 
type, neuroendocrine type, and RCAs of the metanephroid 
type are not mentioned in Figure 1 because of the limited 
data available.. One of the first genetic alterations in tumor 
development, associated with the epithelia of the proximal 
tubule, are trisomy 7 and loss of the Y chromosome, proba­
bly resulting in hyperplastic and dysplastic changes.
But trisomy 7 and loss of Y may have limited or no sig­
nificance with respect to RCC development and progres­
sion, because these chromosomal alterations have been 
demonstrated to be present in normal cells of tumor-adja- 
cent kidney parenchyma rather than in the tumor itself [9] 
and trisomy 7 and trisomy 10 can be found in subpopula­
tions of tumor-infiltrating lymphocytes [10], Recently, oc­
currence of trisomies 5, 8, and 18 has also been reported 
for non-neoplastic kidney tissue [11, 12]. A gain of chromo­
some 7 may confer growth advantage to some malignant
cells, because of the presence of the epidermal growth 
factor receptor on this chromosome [13], The loss of one 
sex chromosome has been observed frequently. The non- 
random loss of the Y chromosome in RCC remains obscure 
and is possibly age-related [14, 15]. The most frequent find­
ing in RCCs of the clear cell type is a deletion or unbalanced 
translocation involving the short arm of chromosome 3 
[16-18].
The breakpoints appear to cluster in region 3pll-p21, 
usually at 3pl4. Involvement of the long arm has seldom 
been described. Recently, the relevant tumor suppressor 
gene responsible for the hereditary forms (von Hippel- 
Lindau disease) has been identified [19], This gene seems 
also to play a role in the development of the sporadic forms, 
probably in combination with other gene(s) [20, 21]. More­
over, a recent report suggests the presence of clear cell 
RCAs, showing only one deletion at 3p (3 p -  in Fig, 1), 
either 3pl4 or 3p25, whereas subsequent loss of the 3p21 
region results in clear cell RCCs (3p= in Fig. 1) [22], Also a 
(partial) trisomy of chromosome 5, especially the 5q22-qter 
segment, is frequently found in the clear cell tumors as well 
as trisomy 12, and 20, loss of chromosomes 8, 9,13,14, and 
structural abnormalities of the long arm of chromosomes 6 
and 10 [18, 23-26, own observations].
RCAs of the chromophilic type show a typical pattern 
of numeric aberrations: Le -Y , +7, (+7), +17. Trisomy 3 
is also frequently found [27-31]. Trisomy of chromosomes 
'12, 16, and 20 has been associated with the progression 
from the adenoma into the carcinoma stage, i.e. RCCs of 
the chromophilic type [28, 32]. Conflicting data exist
Figure 1 Proposed oncogenetic model for renal cell tumors.
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about papillary RCC showing rearrangement of the critical 
3p segment, at least at a molecular level [33, 34],
Several hum an renal cell carcinomas with X;autosome 
translocations have been reported in recent years (see for 
review [35]], The t(X;l)(pll.2;q21) appears to be a specific 
primary anomaly, suggesting that tumors with this translo­
cation form a distinct subgroup of chromophilic RCC, 
showing clear cell features. These tumors preferentially 
occur in male patients [36-39], although one female case 
has recently been described [40].
Chromophobic carcinomas show multiple losses of entire 
chromosomes, i.e. loss of chromosomes 1, 2, 6, 10, 13, 17,
21, and the Y chromosome, leading to a low chromosome 
number. They also show quantitative as well as qualitative 
changes in mitochondrial DNA [41, 42]*
Two reports with cytogenetica data from collecting 
duct carcinomas revealed conflicting findings of monosomy 
for chromosomes 1, 6, 14, 15, and 22 in one case [43] and 
trisomies 7, 12, 16, 17, and 20 in the other [44], Schoenberg 
et al. [45] reported involvement of the short arm of chro­
mosome 8 related to poor prognosis and loss of the long 
arm of chromosome 13, both in three out of six cases.
There are no cytogenetic data on RCCs of the transitional 
cell type. Only one case with cytogenetics of RCC of the 
neuroendocrine type has been published revealing structural 
and numerical aberrations of chromosome 13 [46]. Molecu­
lar analysis of another case showed LOH on 3p21 [47]. 
Both transitional cell RCCs and neuroendocrine RCCs are 
not mentioned in Figure 1. RCAs of the oncocytic type seem 
to be characterized by mitochondrial DNA changes [48,49], 
a feature they share with the chromophobic carcinomas, 
At least two subgroups can be distinguished: one character­
ized by translocations involving l l q l3  [50] and one by the 
combination of — Y, - 1  [51, 52]. Loss of chromosomes 1 
and Y is also observed in chromophobic carcinomas, From 
a cytogenetic point of view, oncocytomas showing —Y, - 1  
might progress to chromophobic carcinomas through addi­
tional chromosome losses (see Figure 1]. This might explain 
why oncocytomas, which are considered to be benign neo­
plasms, occasionally show malignant behavior. One case 
of RCA of the metanephroid type (not mentioned in Figure 
1) revealed a normal (46,XY) karyotype [53].
A strong correlation between pronounced telomere 
shortening and the appearance of telomeric associations of 
chromosomes was found in three renal cell tumor subtypes 
(RCAs of the oncocytic type, RCAs/RCCs of the chro- 
mophobic type, and RCCs of the chromophilic type), sug­
gesting an etiologic role of the loss of telomeric DNA 
repeats in the formation of telomeric associations and a 
possible involvement of this mechanism in the pathogene­
sis of chromosome aberrations [54].
CYTOGENETICS AND TUMOR PROGRESSION ;
t
In the clear cell RCCs, monosomy 8, 9, 13, and 14, and 
trisomy of chromosomes 12 and 20 seem to correlate with 
a  higher grade, and thus progression. Also structural aberra­
tions (and probably loss of heterozygosity) of chromosomes 
5q, 6q, 8p, 9, lOq, and 14q are associated with tumor pro­
gression [18,55, own observations]. In RCAs/RCCs of the
chromophilic type polysomies 12,16, and 20 are associated 
with progression from adenoma into carcinoma stage. The 
loss of the extra chromosome 17p in RCCs of the chro­
mophilic type tend to be related to the higher grade neo­
plasms, in which also a higher frequency of trisomy 20 is 
found [56]. It seem that tumors derived from the proximal 
tubule (RCAs/RCCs of the clear cell and the chromophilic 
cell type) share secondary karyotypic changes and this 
might suggest that many of the tumor suppressor loci 
involved may be common to the etiology of both forais [57].
Sarcomatoid transformation in RCC represents the 
highest form of de differentiation [7]. Sarcomatoid variants 
of RCC can in principle be deduced from all the basic cell 
types. Cytogenetic data on sarcomatoid RCC is scarce. 
Grammatico et al. [58] reported a sole case of pleuric effusion 
of sarcomatoid RCC with structural abnormalities of chromo­
somes 1,5, 16,and 19. Others have found a relation between 
p53 mutations and sarcomatoid RCC [59]. Because it is not 
clear which basic cell types are involved in the above 
mentioned cases, these data are not included in Figure 1.
CONCLUSION
Renal cell cancers (RCCs) are epithelial neoplasms that 
demonstrate a diversity of morphologic characteristics and 
clinical manifestations. The classification of the heteroge­
neous group of RCC is still a matter of debate.
Different subtypes of renal cell carcinoma might originate 
from cells of the different parts of the renal tubulus. Taken 
together, cytogenetic and molecular genetic studies of recent
somal abnormalities correlate with different histologic 
subtypes of renal tumors. Chromosomal abnormalities are 
believed to be responsible for neoplastic transformation, 
tumor growth, and tumor progression [60]. Oncogenetic 
studies might reveal the cell of origin, oncogenetic steps, 
and relationship of tumors. The view of a relation between 
renal cell adenomas and carcinomas is strengthened by 
the fact that oncocytomas and adenomas occasionally 
show a malignant behavior. A reasonable explanation for 
this exceptional behavior is that oncocytomas and ade­
nomas probably represent the benign side of a spectrum of 
renal cell tumors, with renal cell carcinoma at the other 
extreme. If the “spectrum” concept for adenomas and car­
cinomas is correct, then it may be expected that there 
would also exist an overlap in some of the characteristics 
of these benign and malignant tumors. Referring to this 
concept, the chromophobic carcinoma could be the malig­
nant counterpart of the oncocytoma. Both show marker 
proteins and ultrastructural features of the distal nephron, 
thus disproving the broadly accepted hypothesis that all 
renal cell cancers are related to the proximal tubulus.
At the (cyto)genetic level, this oncogenetic sequence 
might be envisaged as depicted in Figure 1,
Thus, (cyto)genetic studies of renal cell adenomas, 
various subtypes of carcinomas, and oncocytomas will 
contribute to abetter understanding of the biology of these 
tumors, and reveal key information on the process of tu* 
morigenesis and tumor behavior. This information may open 
new opportunities for (early) diagnosis and specific therapy.
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